Skip to content

Cannabis use frequency may differentially impact cognitive performance in young adults with and without HIV

S. Nichols, Kun Yang, D. Staley, J. O'Keeffe, X. Tu, Joseph P Happer, K. Hall, Ming-Xing Deng, Sarah Hasheem, Runze Wang, Amy E Lansing, Joanna Jacobus, C. Fennema-Notestine

Frontiers in adolescent medicine March 26, 2026 DOI: 10.3389/fradm.2026.1716084 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Cross-sectional observational study Peer reviewed
Sample size 99
Population Young adults aged 18-24, comprising 38 with HIV (YWH) and 61 without HIV (YWoH), 32% White
Topics Cannabis
Key findings Heavy cannabis use (at least 5 days per week in the past 30 days) was associated with worse fluid cognition, immediate and delayed word list recall, processing speed, and executive functions compared with no use, and with worse story recall and executive functions compared with mild/moderate use. Participants with HIV showed worse cognition than those without on several measures. Exploratory continuous analyses suggested a linear relationship of greater use with worse performance in young adults without HIV, but non-linear relationships suggesting better performance with mild/moderate use on some memory and executive measures in those with HIV.

Abstract

Introduction: Increased cannabis use in young adults may influence brain health and neurodevelopment. In the context of chronic HIV-associated neuroinflammation, however, mild cannabis use may attenuate negative outcomes through anti-inflammatory effects. More frequent cannabis use may remain deleterious to both young adults with HIV (YWH) and without HIV (YWoH). We explored cross-sectional associations between cannabis use frequency and cognitive performance in YWH and YWoH.

Method: Participants aged 18-24 included 38 YWH and 61 YWoH (32% White) who completed cognitive tests of verbal memory, processing speed, working memory, executive functions, and overall fluid cognition. Timeline follow-back interviews assessed days of cannabis use (past 30, 180 and 365 days). Primary analyses focused on 30-day use, categorized as: no use, mild/moderate (1-<5 days used/week) and heavy (≥5 days used/week). Generalized estimating equations modeled associations of HIV, cannabis use category, and their interaction with cognitive outcomes; trend analyses used cannabis frequency as a continuous variable. Due to group differences in proportion of females, sex differences could not be addressed.

Results: YWH had worse performance than YWoH in fluid cognition, memory, processing speed, and executive functioning. Adjusting for HIV status, heavy 30-day use, versus no use, was associated with worse performance on fluid cognition, immediate and delayed word list recall, processing speed and executive functions. Relative to mild/moderate use, heavy use was associated with worse immediate and delayed story recall and executive functions. Results were similar for 180- and 365-day use. Interactions between HIV status and 30-day cannabis use category were not significant, although exploratory analyses employing cannabis use as a continuous measure suggested a linear relationship for YWoH of greater use with worse cognitive performance, while for YWH, non-linear relationships suggested better performance with mild/moderate use on some memory and executive functioning measures.

Conclusions: These results suggest ongoing heavy cannabis use is associated with worse cognitive performance among young adults. For YWH, however, mild to moderate levels of cannabis use may have a protective effect possibly through altering chronic neuroinflammation, although causality cannot be determined in this cross-sectional study. Understanding differential, population-specific effects of cannabis use frequency may be important in setting use guidelines.

Comparable studies

Other cross-sectional and survey studies on cannabis, most cited first.

Study Year Design Participants
Cannabis use before age 15 and subsequent executive functioning 104 chronic cannabis users (49 early-onset before age 15, 55 late-onset after age 15)... 2011 Observational cross-sectional study n = 148
Patterns of simultaneous polysubstance use in drug using university students Drug-using university students 2006 Cross-sectional survey n = 149
Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey Online survey respondents 2020 Cross-sectional survey
User perceptions of the benefits and harms of hallucinogenic drug use: A web-based questionnaire study Users of hallucinogenic drugs who completed a web-based questionnaire 2010 Cross-sectional survey n = 600
Illicit Use of LSD or Psilocybin, but not MDMA or Nonpsychedelic Drugs, is Associated with Mystical Experiences in a Dose-Dependent Manner Adults recruited from the MAPS website and newsletter, most reporting use of various... 2012 Cross-sectional survey n = 337

Citations in the library

Explore topics